$MMSI

Merit Medical (NASDAQ: MMSI) HR chief gifts 650 shares

Merit Medical (MMSI) HR chief Michel J. Voigt gifted 650 shares of common stock as a charitable donation on 2026-08-24. Post-transaction, Voigt holds 45,412 direct shares and 2,265 indirect shares via a 401(k) plan. Voigt also holds non-qualified stock options on 17,542 shares with varying exercise prices and expiration dates.

Original reporting
Published Aug 25, 2026, 8:43 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 1:53 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$MMSI
Neutral
high confidence
Mentioned
$MMSI
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$MMSINeutralLow
01

Why it matters

The filing is a routine disclosure with negligible market impact.

02

Market read

Limited relevance; only informs investors of a minor insider transaction.

03

What to watch

Potential future dilution if the insider exercises options, but not immediate.

Relevance 4/10Novelty 4/10Timing: gift reported on 2026-08-24

Background

Merit Medical Systems Inc. (NASDAQ:MMSI) filed a Form 4 showing a charitable gift of 650 shares by its HR chief.

Company-level read

Ticker impact

$MMSINeutralHigh confidence
Context

Form 4 disclosed HR chief Michel J. Voigt gifted 650 Merit Medical shares on 2026-08-24, increasing his direct holdings to 45,412 shares.

Expected impact

Minimal impact; price likely unchanged.

Evidence & confidence

Insider gifts of this size rarely move the stock and no cash changed hands.

Market effects

None; the transaction does not affect the medical device sector.

None; limited to a single insider's holdings.

None

Counterpoint

Even small insider gifts can signal confidence, but the size is too trivial to act on.

Key entities

  • Michel J. Voigt

    Chief Human Resources Officer of Merit Medical

Related articles

$MMSIMedAI 8/10

Merit Medical Systems (MMSI) Is Up 6.2% After Raising 2026 Outlook And Q2 Beat Expectations – Has The Bull Case Changed?

Merit Medical Systems (MMSI) reported Q2 2026 sales of $418.84 million and net income of $38.8 million, and raised its full-year 2026 revenue outlook to $1.63 billion to $1.64 billion, according to the company. The article notes ongoing product recalls and reimbursement risks and mentions a 2029 narrative of about $1.8 billion revenue and $213.7 million earnings.

$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

$MMSIMedAI 8/10

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results - Merit Medical

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million. Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.

$MMSIMedAI 8/10

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Medical device company Merit Medical Systems (NASDAQ: MMSI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $418.8 million. The company’s full-year revenue guidance of $1.64 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 24% above analysts’ consensus estimates. Is now the time to buy Merit Medical Systems? Find out by accessing our full research report, it’s free.